These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7460352)

  • 21. [Clinical results in the treatment of acromegaly with CB-154].
    Ibayashi H; Aiba H; Kato K
    Horumon To Rinsho; 1977 Dec; 25(12):1346-8. PubMed ID: 598043
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term therapy of acromegaly and gigantism by using CB-154].
    Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M
    Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of CB-154 administration in acromegaly].
    Nakagawa K; Obara T
    Horumon To Rinsho; 1977 Dec; 25(12):1274-6. PubMed ID: 598017
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effect of CB-154 in acromegaly].
    Miyashita M; Kaneko K; Yamada Y
    Horumon To Rinsho; 1977 Dec; 25(12):1306-7. PubMed ID: 598030
    [No Abstract]   [Full Text] [Related]  

  • 25. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic experience with CB-154 in acromegaly].
    Abe K; Shigemasa C; Takeda A; Ikeda T; Kitahara K
    Horumon To Rinsho; 1977 Dec; 25(12):1338-40. PubMed ID: 598040
    [No Abstract]   [Full Text] [Related]  

  • 27. Amitriptyline-induced suppression of growth hormone in acromegaly.
    Glass AR; Schaaf M; Dimond RC
    Psychoneuroendocrinology; 1980 Jan; 5(1):81-6. PubMed ID: 7190314
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term administration of CB-154 in acromegaly].
    Kanezuka H; Makino E; Matsushima Y; Osegawa M; Yamamoto A
    Horumon To Rinsho; 1977 Dec; 25(12):1282-5. PubMed ID: 598020
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of blood somatotropin and phosphorus levels after administration of 2-bromo-alpha-ergocryptine].
    Romiti A; Martelletti P; Giacovazzo M
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2257-9. PubMed ID: 754723
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No effect of bromocriptine in acromegaly: a controlled trial.
    Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
    N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum growth hormone response to bromocriptine during a glucose tolerance test in acromegaly.
    Cassar J; Mashiter K; Sullivan G; Joplin GF
    Acta Endocrinol (Copenh); 1976 May; 82(1):39-46. PubMed ID: 946714
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term use of parlodel in acromegaly].
    Pisarskaia IV; Zefirova GS; Ibragimova GV
    Ter Arkh; 1984; 56(10):107-10. PubMed ID: 6523351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of a single dose of dihydroergotoxine on the growth hormone level in acromegaly].
    Kołodziej-Maciejewska H
    Endokrynol Pol; 1981; 32(4):309-14. PubMed ID: 7308170
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors determining the effectiveness of CB-154 in the treatment of acromegaly.
    Hanew K; Sasaki A; Sato S; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1983 Jan; 139(1):91-5. PubMed ID: 6404005
    [No Abstract]   [Full Text] [Related]  

  • 39. Bromocriptine in treatment of acromegaly: Australian experience.
    Lording DW; Burger HG
    Med J Aust; 1978 Nov; 2(3 Suppl):34-5. PubMed ID: 745580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine and acromegaly: therapeutic implications.
    Brooks AP; Stephen PJ; Nairn IM; Strong JA
    J R Soc Med; 1979 Aug; 72(8):562-4. PubMed ID: 552555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.